US EditionIrving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
Summary by Dallas Innovates
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
Dallas Innovates, Every Day: Here's what's new + next in North Texas. Irving-based Caris Life Sciences, a leader in precision oncology, has filed for an initial public offering, the company announced. Caris has applied to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol CAI. The number of shares and the price range for the proposed offering have not yet been determined.…The post Irving’s Caris Life Science…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
